Lacer to invest eur 12 million in 2010

pharmaceutical group lacer plans to invest eur 12 million next year in r&d projects aimed at strengthening its competitive position. the company will close this year with investments of more than eur 12 million. lacer has four divisions including pharmaceuticals, cosmetics and branded generics.

for 2010, the company plans to focus on new drug research while strengthening its links with biotech companies. lacer has a staff of 550 employees and last year posted revenue of eur 140 million.

source: el economista 25/11/2009